OssDsign

We are excited to be here for the first day of the AAOS 2025 Annual Meeting in San Diego! This prestigious gathering brings together the best in orthopedics, and we’re proud to showcase OssDsign Catalyst®—our advanced solution for bone regeneration and enhanced patient outcomes. Stop by booth 5116 to learn more about our commitment to innovation in orthopedic care. Looking forward to a day of impactful discussions and connections! #OssDsign #OssDsignCatalyst #AAOS2025 #orthopedics #orthopedicsurgery

We’re excited to announce our participation in the AAOS 2025 Annual Meeting, a leading event for orthopedic professionals worldwide. This gathering is an excellent opportunity to connect with experts, share insights, and showcase OssDsign Catalyst®—our innovative solution in bone regeneration technology. Visit us at booth 5116 to learn how we’re advancing patient outcomes through cutting-edge technology in orthopedic care. We look forward to connecting with you in San Diego! #AAOS2025 #Orthopedics #Innovation #OssDsign

We’re excited to announce our participation in the AAOS 2025 Annual Meeting, a leading event for orthopedic professionals worldwide. This gathering is an excellent opportunity to connect with experts, share insights, and showcase OssDsign Catalyst®—our innovative solution in bone regeneration technology. Visit us at booth 5116 to learn how we’re advancing patient outcomes through cutting-edge technology in orthopedic care. We look forward to connecting with you in San Diego! #AAOS2025 #Orthopedics #Innovation #OssDsign

We had the privilege of bringing together our powerhouse team of sales managers for our 2025 National Sales Meeting, and let’s just say—WOW. Their passion, dedication, and relentless drive to serve our customers is truly inspiring. A huge congratulations to our award winners: Patrick Denney, Steve Poss, and Chris Collins. Your commitment to excellence is setting new standards, and we couldn’t be prouder. #NationalSalesMeeting #SalesExcellence #OssDsign #Catalyst

OssDsign is excited to announce that we have successfully enrolled 300 patients in our PROPEL spinal fusion registry, reaching our initial target ahead of schedule. Since launching PROPEL in March 2022, we have been dedicated to collecting real-world data on OssDsign Catalyst, our nanosynthetic bone graft designed to improve spinal fusion outcomes. As our CEO, Morten Henneveld, has emphasized, gathering strong clinical evidence is a top priority for us in demonstrating the effectiveness of OssDsign Catalyst. Given the high level of interest from surgeons and the value of the data we are collecting, we plan to continue enrolling patients to further strengthen our findings. Through PROPEL, we are assessing spinal fusion success using imaging 12 months post-surgery, while also evaluating patient quality of life, neurological function, and overall safety. Read the full press release here: https://buff.ly/3Djt6aa #spinesurgery #catalyst #spine #neurosurgery #orthopedics

Day 1 at Spine Summit 2025 in Tampa, FL! This esteemed event offers a valuable platform to connect with top experts in spine care and present OssDsign Catalyst®—our advanced solution for promoting spine health and enhancing patient outcomes. Stop by our booth to explore our technology and join insightful discussions focused on the future of spine care. Here’s to a productive and inspiring first day! #SpineSummit2025 #OssDsign #SpineInnovation #BoneHealing

A huge thank you to Dr. Nauman Chaudhry for delivering an insightful presentation on "Early Results with a Novel Nanosynthetic Bone Graft" at Southern Neuro Society Annual Meeting 2025! Dr. Chaudhry shared compelling data on the efficacy of OssDsign Catalyst, highlighting its ability to drive rapid and reliable bone formation—even in challenging, poorly vascularized environments. The discussion on its nanosynthetic design and dual bone formation pathways sparked great engagement from attendees eager to learn more about this innovative technology. Your expertise and dedication to advancing the field are truly appreciated, Dr. Chaudhry! To learn more about how OssDsign Catalyst is redefining bone graft technology, visit: https://buff.ly/4gAK4OX #SpineSurgery #BoneGraft #Orthobiologics #DualBoneFormationPathways #OssDsignCatalyst #EndochondralOssification

We’re excited to announce that OssDsign will be joining the upcoming Spine Summit 2025, hosted by the AANS/CNS Section on Disorders of the Spine and Peripheral Nerves. This event brings together thought leaders and innovators to shape the future of spine care, and we’re honored to be part of it. Join us to explore OssDsign Catalyst® and our latest advancements in spine technology. We look forward to seeing you in Tampa, FL! #SpineSummit2025 #SpineCare #OssDsign #Innovation

A fantastic turnout for Dr. Peter Whang’s insightful presentation on "Early Results with a Novel Nanosynthetic Bone Graft" at Selby Spine! Dr. Whang shared compelling early clinical and preclinical data showcasing the potential of OssDsign Catalyst® to drive rapid and reliable bone formation, even in challenging low-oxygen environments. The audience was highly engaged, eager to learn about the dual bone formation pathways, and the clinical evidence supporting Catalyst as a next-generation orthobiologic solution. Thank you, Dr. Whang, for your expertise and for leading such an impactful session! And thank you to everyone who attended and contributed to the discussion. To learn more about how OssDsign Catalyst is redefining bone graft technology, visit: https://buff.ly/4gAK4OX #SpineSurgery #BoneGraft #Orthobiologics #DualBoneFormationPathways #OssDsignCatalyst #EndochondralOssification

Grab your coffee and come learn about Catalyst! You don't want to miss Dr. Nauman Chaudhry “Early Results with a Novel Nanosynthetic Bone Graft" presentation during the Southern Neurosurgical Society Annual Meeting general session this morning at 8:05am EST. #OssDsign #OssDsignCatalyst #EndochondralOssification #RedefiningOrthobiologics